Focus on Animal Vaccine, Diagnosis Test Kit, Medicine,  Feed Additives and Pet Food

1. The first classic lentogenic vaccine in China with extremely high safety: The farrowing is still good after the pregnant sows are vaccinated with a 10-fold dosage.
2. Stable genetic traits: The CH-1R strain is a classic lentogenic virus with good stability, the seed strain is passed for 160 generations. The homology between the virus before and after passage is 99.2%.
3. The challenge test showed the product has a cross-protective effect on mutant strains.
4. Triple detections of raw materials, production processes, and finished products to ensure no contamination by mycoplasma and other 13 exogenous pathogens.

1. The particle size in the vaccine is homogenous with low stress reaction.
2. Water-Oil-Water (W/O/W) adjuvant.
 - Rapidly releasing of the outer antigen, rapidly producing immunity
 - Slowly releasing of inner antigen, producing long time immunity.

1. Advanced purification and production technology to produce the high-purity vaccine, the bacterial content≥ 2.9 billion units per ml.
2. The product contains K88, K99 and 987P antigens, which are effective against yellow and white piglet scour.
3. Medical-grade aluminium glue adjuvant ensures that the vaccine is easily sucked out and injected.
4. The F18 fimbrial antigen can be added to prevent Edema Disease through customization.

1. High titer, antigen titer is stable for different batches.
2. Classic Bartha-K61 strain with a natural deletion of the gE gene, easy to differential diagnosis and prevention of pseudorabies.
3. Triple detections of raw materials, production processes, and finished products to ensure no contamination by mycoplasma, BVDV or other exogenous pathogens.

1. Each dose contains ≥ 15,000 RID
2. Large-scale production process of bioreactors, the antigen liquid contains more than 1 million RID/ml, and the potency between different batches is stable.
3. Using real-time PCR detection to ensure no BVDV and other exogenous pathogens.
4. Low serum culturing and low stress reaction after administration.

1. The particle size in the vaccine is homogenous with low stress reaction.
2. Water-Oil-Water (W/O/W) adjuvant.
 - Rapidly releasing of the outer antigen, rapidly producing immunity
 - Slowly releasing of inner antigen, producing long time immunity.

1. Long time encephalitis vaccine manufacturing experience ensures the qulity of the product.
2. High purification for the virus strain with high stability.

1. High safety with attenuated virus, PoRV is passed for 120 generations.
2. Strict production control and testing ensure the quality and purity of the vaccine.
3. Advanced cell production technology ensures stable antigen titer.
4. Producing cellular immunity, humoral immunity, and mucosal immunity.
5. PoRV G5+G9 are contained in the vaccine to provide efficient protection for the PoRV.

1. The vaccine is a whole virus vaccine (WVV) with good virus structural integrity and high immunogenicity.
2. The only one in China that tests IPMA titer, the IPMA tier will be 1:960 after 14 days of the first administration.
3. High purification to provide good and efficient immune response, remove 88% miscellaneous proteins, and reduce immune interference and stress reaction.

(1) The vaccine contains dominant strains of the pandemic with high antigen titer.
(2) Medical grade aluminium glue adjuvant, excellent antigen adsorption and low-stress reaction.
(3) The product can be vaccinated for the stages of the sows, and the vaccination for the pregnant sow can prevent and control the diarrhea of piglets in the farrowing house.
(4) The new PEDV G2a type is updated in the product.
(5) Through emergency immunization, rapidly increase breast milk antibody levels and reduce the virus in breast milk
 

1. Antigen content>10^6.3TCID₅₀/head, stable quality in different batches.
2. Antibodies can be detected after 7 days of administration and neutralizing antibodies can be detected after 14 days.
3. It can protect both classical and variant strains
4. High temperature accelerated for 5 days or repeated freeze-thaw for 3 times, vaccine antigen loss<10%